Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company